MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.

Quarter-by-quarter ownership
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$13,282,000
+9.4%
85,990
-1.3%
1.46%
+4.1%
Q3 2021$12,136,000
+406.9%
87,110
+377.4%
1.40%
+424.3%
Q2 2021$2,394,000
+12.3%
18,245
+30.5%
0.27%
+8.5%
Q1 2021$2,132,000
-74.9%
13,985
-77.7%
0.25%
-78.4%
Q4 2018$8,504,000
-33.0%
62,671
+35.6%
1.14%
-0.7%
Q3 2018$12,686,000
-20.7%
46,217
-40.2%
1.15%
-21.8%
Q2 2018$16,004,000
+14.5%
77,247
-8.7%
1.47%
+7.3%
Q1 2018$13,982,000
-4.5%
84,652
-20.8%
1.37%
+32.7%
Q4 2017$14,634,000
-24.1%
106,887
-24.5%
1.03%
-18.6%
Q3 2017$19,283,000
-8.3%
141,626
-18.3%
1.27%
-9.9%
Q2 2017$21,039,000
+14.0%
173,291
-0.7%
1.41%
+15.0%
Q1 2017$18,463,000
+2.2%
174,456
-1.9%
1.23%
+10.3%
Q4 2016$18,064,000
-14.7%
177,771
-14.3%
1.11%
-10.6%
Q3 2016$21,182,000
+1.3%
207,496
+18.3%
1.24%
+2.1%
Q2 2016$20,912,000175,3311.22%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders